Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lofexidine for Opiate Withdrawal
NCT00032942Phase 3Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Apr 2001
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in opioid withdrawal comparing Lofexidine with Placebo (2 arms). Primary endpoints: Opiate withdrawal symptoms and Potential Abuse Liability. Started Apr 2001; status: completed.
02
Drugs
lofexidine
03
Conditions
opioid withdrawal
Beyond the preview
Go deeper on NCT00032942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00032942.